PARTICULARS | PAGE NO. | Executive summary | Iii | 1.Introduction | | 1.1 Purpose and scope of the project | 6 | 1.2 Methodology | 7 | 1.3 Limitation of study | 8 | 1.4 Literature Review | 8 | 2.Industry profile | | 2.1 The Global Pharma market | 9 | 2.2 The Indian Pharma market | 9 | 3.Ratio Analysis | 11 | 4.Working capital management | 12 | 5.Phase І : Net Operating Cycle | | 5.1 Operating cycle Ankleshwar unit | 13
Premium Inventory Working capital Cash conversion cycle
Ranbaxy – Daiichi Sankyo Deal Akash Bangani Dipika Bhura Gaurav Khetan Neetu Rathod 12065 12077 12082 12118 Agenda • • • • • • • • • • Industry Overview Companies’ Profiles Snapshot of the deal Financing the deal Benefits to Daiichi Benefits to Ranbaxy Synergies Post Acquisition challenges Recent Developments Conclusion Indian Pharmaceutical Industry • Present size of $14 billion. • Ranks 4th in world in terms of production and 13th in terms of consumption. • Highly fragmented. 325 large
Premium Generic drug Pharmaceutical industry 3rd millennium
The Betapharm Acquisition: DRL ’s Inorganic Growth Strategy in Europe DRL GAINS A FOOTHOLD IN EUROPE On February 15‚ 2006‚ Dr. Reddy ’s Laboratories Limited (DRL)‚ a leading Indian pharmaceutical company‚ acquired the fourth-largest generic pharmaceutical company in Germany‚ betapharm Arzneimittel GmbH (betapharm) from the 3i Group PLC (3i) for US$570 million (480 million). The deal also included the beta institute for socio medical research GmbH ’ (beta Institute)‚ a non-profit research
Premium Generic drug Pharmaceutical industry
technological industries to keep their employees up to date. With continuous advancements in technology‚ the needs and requirements of the company change‚ and so will the needs and requirements of employees. Jim Malanson‚ vice president of technical development at Palo Alto‚ believes that any technology organization needs to ¡°keep pace with the speed at which new products are coming to market in their sector¡± (reference). The pharmaceutical company is in a fast paced industry‚ and it is important
Free Pharmacology Pharmacy Vice President of the United States
acted in a socially responsible and ethical manner with regard to Vioxx. Vioxx is a prescription medicine used to relieve signs and symptoms of arthritis‚ acute pain in adults and painful menstrual cycle and Merck was one of the world’s leading pharmaceutical firms. Corporate social responsibility means that a corporation should act in a way that enhances society and its inhabitants and be held accountable for any of its actions that affect people‚ their communities‚ and their environment. I didn’t
Premium Pharmacology Clinical trial Pharmaceutical industry
Josh Boger – R&D Portfolio Management in October 2003 Analysis of Pharmaceutical Industry: As mentioned in the case‚ Pharmaceutical industry was experiencing a significant growth between 1993 and 2003. New technologies and approaches such as Rational Drug Design‚ High Throughput Screening‚ etc. were advancing drug discovery process to a new level. There were many drugs being approved and commercialized during this period and some of them have become blockbusters in the market. As companies have
Premium Drug discovery Pharmacology Clinical trial
[pic] BRAC UNIVERSITY BRAC BUSINESS SCHOOL INTRODUCTION TO BUSINESS (BUS-101) Class/Sec: 3 Prepared by Md.wahidur Rahman 09304076 Farah Enayet Tonny
Premium Pharmaceutical industry Pharmacology Pharmacy
INTRODUCTION Johnson and Johnson have revolutionized the way people think about health care‚ and has easily become the pinnacle of success by doing so. Pioneers of the health care industry and overall human health and well being‚ Johnson and Johnson is guided by its “Our Credo” and founding principle that “doctors and nurses should use sterile sutures‚ dressings and bandages to treat peoples wounds” (Johnson and Johnson - Our History). Most of Johnson and Johnson’s success can be attributed to
Premium Johnson & Johnson 2009 Health care
Deontological Case to Direct-to-Consumer Pharmaceutical Drug Advertising Introduction Direct-to-consumer advertising of pharmaceutical drugs is a controversial issue; is it ethical or does it lead to self-diagnosis and take advantage of those that desperately hope and need a cure? Pharmaceutical companies are using direct-to-consumer advertising through internet ads‚ TV ads and other mass media to target as many consumers as possible. Currently‚ New Zealand and the United States are the only two
Premium Pharmacology Drug Pharmaceutical industry
Merck’s opportunities and threats? 2. Internal (use VRIO framework)- what are Merck’s strengths & weaknesses? 3. What is Merck’s performance trend? 4. What strategic actions can Merck take to gain and sustain a competitive advantage in the pharmaceutical industry and why? 1. Merck’s opportunities and threats PESTEL FRAMEWORK - Threats A lot of competition from piers Expiring patents Outdated technology Recall of drugs such as (VIOXX) can hurt the company brand - Opportunities
Premium Pharmacology Generic drug Globalization